1,369 results match your criteria Thyroid Papillary Carcinoma Early

Survival outcomes of low-risk papillary thyroid carcinoma at different risk levels: a corollary for active surveillance.

Front Endocrinol (Lausanne) 2023 7;14:1235006. Epub 2023 Sep 7.

Department of Oncological Surgery, Shaoxing Second Hospital, Shaoxing, China.

Background: This study aims to compare the outcomes of active surveillance (AS) in low-risk papillary thyroid carcinoma (PTC) patients with different tumor sizes and lymph node metastasis status, in order to establish appropriate management strategies. By analyzing these results, this study provides valuable insights for the effective management of such patients, addressing the issues and challenges associated with AS in practical clinical practice.

Methods: The study utilized the SEER database supported by the National Cancer Institute of the United States, extracting data of PTC diagnosed between 2000 and 2015. Read More

View Article and Full-Text PDF
September 2023

A case report of anaplastic thyroid carcinoma transformed from small papillary carcinoma successfully detected by ultrasonography in its early stage with review of literature.

Endocr J 2023 Sep 16. Epub 2023 Sep 16.

Department of Endocrinology, Noguchi Thyroid Clinic and Hospital Foundation, Oita 874-0902, Japan.

An 82-year-old woman was referred to our hospital because of a suspicious thyroid nodule. She was diagnosed with papillary microcarcinoma with a maximum diameter of 9 mm based on ultrasonography and fine-needle aspiration (FNA) cytology. She preferred observation without surgery. Read More

View Article and Full-Text PDF
September 2023

Radioactive iodine therapy strategies for distinct types of differentiated thyroid cancer: a propensity score-matched analysis.

Front Endocrinol (Lausanne) 2023 17;14:1158581. Epub 2023 Aug 17.

Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Background: The management guidelines of radioactive Iodine (RAI) therapy for distinct types of differentiated thyroid carcinoma (DTC) were the same in clinical practice. However, in distinct types DTC, differences in RAI avidity and response existed and the effect of RAI therapy could not be equated.

Methods: DTC patients' data in SEER database were extracted to perform retrospective analysis. Read More

View Article and Full-Text PDF
September 2023

Cost-effectiveness of active surveillance versus early surgery for thyroid micropapillary carcinoma based on diagnostic and treatment norms in China.

Front Endocrinol (Lausanne) 2023 16;14:1166433. Epub 2023 Aug 16.

Department of Oncological Surgery, First Hospital of Lanzhou University, Lanzhou, China.

Objectives: In this study, we compared the cost-effectiveness comparison of the active surveillance (AS) and early surgery (ES) approaches for papillary thyroid microcarcinoma (PTMC) from the perspective of the Chinese healthcare system.

Methods: We performed a cost-effectiveness analysis using a Markov model of PTMC we developed to evaluate the incremental cost-effectiveness ratio of AS and ES. Our reference case was of a 40-year-old woman diagnosed with unifocal (<10 mm) PTMC. Read More

View Article and Full-Text PDF
September 2023

Cost-Effectiveness of Active Surveillance Compared to Early Surgery of Small Papillary Thyroid Cancer: A Retrospective Study on a Korean Population.

J Korean Med Sci 2023 Aug 28;38(34):e264. Epub 2023 Aug 28.

Department of Family Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Background: Recently, active surveillance (AS) has been introduced as an alternative to early surgery (ES) for the management of papillary thyroid microcarcinoma (PTMC), because of its indolent features and low mortality. However, its cost effects have not been determined and the findings of current studies differ, according to each country's medical system.

Methods: A Markov model was constructed to compare the cost-effectiveness of AS and ES, based on a reference case of a 40-year-old patient diagnosed with PTMC. Read More

View Article and Full-Text PDF

Childhood Malignancies-Clinico-demographic Profile of Patients Attending the Department of Otorhinolaryngology at a Tertiary Care Centre in North-East India.

Indian J Otolaryngol Head Neck Surg 2023 Sep 24;75(3):2006-2016. Epub 2023 Apr 24.

Guwahati, Assam 781032 India Dept. of Otorhinolaryngology, Gauhati Medical College.

Introduction: Malignancies in children are different from those found in adults and are a significant cause of childhood mortality.They have varied clinical presentation depending on site and type of disease.It is essential to recognize the early signs and symptoms of malignancies in childhood, especially those involving head and neck region, so as to reduce childhood mortality and morbidity. Read More

View Article and Full-Text PDF
September 2023

Biomarker Discovery for Early Diagnosis of Papillary Thyroid Carcinoma Using High-Throughput Enhanced Quantitative Plasma Proteomics.

J Proteome Res 2023 Aug 25. Epub 2023 Aug 25.

Precision Medicine Center, Taizhou Central Hospital (Taizhou University Hospital), 999 Donghai Avenue, Taizhou 318000, Zhejiang, P. R. China.

The incidence of thyroid cancer (TC) has been increasing over the last 50 years worldwide. A higher rate of overdiagnosis in indolent thyroid lesions has resulted in unnecessary treatment. An accurate detection of TC at an early stage is highly demanded. Read More

View Article and Full-Text PDF

Second Primary Cancer Among Patients With Papillary Thyroid Carcinoma Following the Chernobyl Disaster.

JAMA Netw Open 2023 Aug 1;6(8):e2329559. Epub 2023 Aug 1.

Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Importance: To our knowledge, there are no complete population-based studies of the risks of developing second malignant tumors after papillary thyroid carcinoma (PTC) in patients following the Chernobyl nuclear accident.

Objective: To study the risk of second primary cancers in patients with PTC after the Chernobyl disaster.

Design, Setting, And Participants: This was a retrospective cohort study conducted in the Republic of Belarus over a 31-year time frame evaluating patients with primary PTC and second malignant tumors. Read More

View Article and Full-Text PDF

Development and validation of a nomogram for risk of pulmonary metastasis in non-papillary thyroid carcinoma: A SEER-based study.

Medicine (Baltimore) 2023 Aug;102(32):e34581

Department of Thyroid Surgery, the First Hospital of Shanxi Medical University, Taiyuan, China.

In this study, a nomogram was established and validated by assessing the risk factors for the development of pulmonary metastases in patients with non-papillary thyroid carcinoma (NPTC) and was used to predict the risk of developing pulmonary metastases. Demographic and clinicopathological variables of patients with NPTC from 2010 to 2015 in the Surveillance, Epidemiology, and End Results database were retrospectively analyzed, and independent risk factors were identified using χ2 tests and full subset regression analysis. Based on this, a nomogram was developed and validated for predicting the risk of pulmonary metastasis in patients with NPTC. Read More

View Article and Full-Text PDF

History of Thyroid Ultrasound.

Robert A Levine

Thyroid 2023 Aug;33(8):894-902

Department of Endocrinology, Thyroid Center of New Hampshire, Nashua, New Hampshire, USA.

From low-resolution images in the 1960s to current high-resolution technology, ultrasound has proven to be the initial imaging modality of choice for thyroid application. Point-of-care ultrasound has brought the technology to the thyroid specialist. Combined with physical examination, it provides real-time information regarding goiter, thyroid nodules, and thyroid cancer. Read More

View Article and Full-Text PDF

Characteristics, staging and outcomes of differentiated thyroid cancer in patients with and without Graves' disease.

J Clin Transl Endocrinol 2023 Sep 26;33:100321. Epub 2023 Jul 26.

University of Kansas Medical Center, Kansas City, KS, USA.

Background: The incidence of thyroid cancer has increased over the last three decades with studies showing incidence of thyroid cancer is higher among patients with Graves' Disease (GD) when compared to Toxic multinodular goiter. We conducted a retrospective study to further investigate characteristics and outcomes in patients with thyroid cancer and GD.

Methods: We retrospectively reviewed 62 patients with a diagnosis of Differentiated Thyroid Cancer (DTC). Read More

View Article and Full-Text PDF
September 2023

Case presentation of the smallest non-functional parathyroid carcinoma and review of the literature.

Eur Arch Otorhinolaryngol 2023 Jul 26. Epub 2023 Jul 26.

Clinic for Endocrine Surgery, Clinical Centre of Serbia, Belgrade, Serbia.

Introduction: Non functional parathyroid carcinoma (PC) is one of the rarest malignant neoplasms. Due to the lack of symptoms and laboratory findings, it is mostly diagnosed in late AQ2 stages, when local invasion and dissemination are already present. However, our case is an exception, because it was detected in early stage, with no local invasion present. Read More

View Article and Full-Text PDF

Metastatic diffuse follicular variant papillary thyroid cancer without cervical lymph node metastasis presenting with symptoms related to hypopituitarism.

Einstein (Sao Paulo) 2023 21;21:eRC0229. Epub 2023 Jul 21.

Department of Endocrinology and Metabolism, University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey.

In this article, we present a case of diffuse follicular variant papillary thyroid carcinoma with pituitary metastasis, which is a rare cause of pituitary metastasis. The follicular variant of papillary thyroid carcinoma is an uncommon variant of papillary carcinoma. A 74-year-old male was presented with weakness, fatigue, and a decreased appetite. Read More

View Article and Full-Text PDF

Transoral and submental endoscopic thyroidectomy (TOaST) for early stage papillary thyroid carcinoma: a real-world data retrospective cohort study.

Surg Endosc 2023 Oct 25;37(10):7649-7657. Epub 2023 Jul 25.

Department of Thyroid Surgery, Affiliated Hospital of Jining Medical University, Jining, 272000, Shandong, China.

Introduction: Although transoral endoscopic thyroidectomy (TOETVA) is widely utilized in clinical practice, some problems and restrictions still remain. Our study compared the perioperative features and early surgical efficacy of TOETVA and a modified transoral and submental endoscopic thyroidectomy (TOaST) in early stage papillary thyroid carcinoma (PTC).

Methods: The clinical data of PTC patients who underwent endoscopic thyroidectomy, including 42 modified TOaST patients and 114 traditional TOETVA patients, were retrospectively collected. Read More

View Article and Full-Text PDF
October 2023

Identification of Serpin peptidase inhibitor clade A member 1 (SERPINA1) might be a poor prognosis biomarker promoting the progression of papillary thyroid cancer.

Life Sci 2023 Sep 23;329:121938. Epub 2023 Jul 23.

Department of Thyroid Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. Electronic address:

Background: Papillary thyroid carcinoma (PTC) is the most prevalent malignancy within the endocrine system, exhibiting a rapid growth rate in recent years. Serpin peptidase inhibitor clade A member 1 (SERPINA1) has been previously proposed as a diagnostic biomarker; however, it's potential molecular relevance and biological function in PTC remains largely unexplored.

Methods: Our study utilized multi-omics bioinformatic data from several public databases, supplemented with transcriptional profiles using our local cohort comprising 79 paired PTC samples. Read More

View Article and Full-Text PDF
September 2023

Differentiating Thyroid Follicular Adenoma from Follicular Carcinoma via G-Protein Coupled Receptor-Associated Sorting Protein 1 (GASP-1).

Cancers (Basel) 2023 Jun 29;15(13). Epub 2023 Jun 29.

Halcyon Diagnostics, 1200 Corporate Blvd. Ste. 10C, Lancaster, PA 17601, USA.

Follicular neoplasms are classified as benign or malignant depending on the presence or absence of capsular and/or vascular invasion. Due to incomplete capsular penetration or equivocal vascular invasion, the evaluation of these features can be challenging using histologic examination. In the current study, we analyzed the involvement of G-protein coupled receptor-associated sorting protein 1 (GASP-1) in the development and progression of thyroid neoplasms. Read More

View Article and Full-Text PDF

Recurrence-free survival and prognosis after adjuvant therapy with radioactive iodine-131 in patients with differentiated thyroid carcinoma.

Sci Rep 2023 Jul 4;13(1):10795. Epub 2023 Jul 4.

Department of Radiation Oncology and Image-Applied Therapy, Kyoto University Graduate School of Medicine, 54, Shogoin Kawahara-cho, Sakyo-ku, Kyoto-shi, Kyoto, 606-8507, Japan.

This study aimed to assess recurrence-free survival (RFS) rates and recurrence-related factors of patients who received adjuvant therapy (AT) with radioactive iodine (RAI) for differentiated thyroid cancer (DTC) following thyroidectomy. We evaluated 284 patients who underwent AT between January 2011 and July 2020 at our hospital. Recurrence was defined as visible recurrent lesions on image analysis or need for repeat surgery with pathologically confirmed recurrent lesions. Read More

View Article and Full-Text PDF

A Study of Cytomorphological Spectrum of Head and Neck Lesions in Pediatric Age Group.

J Cytol 2023 22;40(2):75-80. Epub 2023 May 22.

Department of Pathology, Mahadevappa Rampure Medical College, Kalaburagi, Karnataka, India.

Introduction: Fine Needle Aspiration Cytology (FNAC) is a well-established early diagnostic technique for evaluating mass lesions in adult patients. Now, FNAC in children is gaining acceptance and is used as a first-line investigation in diagnosis of pediatric lesions.

Aims: To analyze the cytomorphologic spectrum of head and neck lesions in pediatric age group with histopathological correlation wherever possible and to study the utility of FNAC in pediatric head and neck lesions. Read More

View Article and Full-Text PDF

Serum Anti-Thyroglobulin Autoantibodies Are Specific in Predicting the Presence of Papillary-like Nuclear Features and Lymphocytic Infiltrate in the Thyroid Gland.

Diagnostics (Basel) 2023 Jun 13;13(12). Epub 2023 Jun 13.

Unit of General and Oncological Surgery, Department of Surgical Oncological and Stomatological Sciences (DICHIRONS), University Hospital AOU Policlinico "P. Giaccone", University of Palermo, 90127 Palermo, Italy.

(1) Background: Previous studies have reported a correlation between serum anti-Thyroglobulin-antibodies (TgAb) and papillary thyroid carcinoma. The aim of our study was to evaluate whether serum TgAb and anti-thyroid-peroxidase antibody (TPO) positivity was also related to pre-neoplastic histological changes such as papillary-like nuclear features (PLNF) and with the presence of lymphocytic infiltrate (LI) in thyroid surgical specimens. (2) Methods: The study was retrospectively carried out on 70 consecutively recruited patients who underwent thyroidectomy for benign process and whose TgAb and TPOAb values were retrieved from clinical records. Read More

View Article and Full-Text PDF

Iodine avidity in papillary and poorly differentiated thyroid cancer is predicted by immunohistochemical and molecular work-up.

Eur Thyroid J 2023 Jul 28;12(4). Epub 2023 Jul 28.

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.

Background: Successful radioiodine treatment of differentiated thyroid cancer requires iodine avidity: that is, the concentration and retention of iodine in cancer tissue. Several parameters have previously been linked with lower iodine avidity. However, a comprehensive analysis of which factors best predict iodine avidity status, and the magnitude of their impact, is lacking. Read More

View Article and Full-Text PDF

Thyroid Cancer Presenting as Neck Pain at a Chiropractic Clinic.

Cureus 2023 May 20;15(5):e39276. Epub 2023 May 20.

Chiropractic and Physiotherapy Centre, New York Medical Group, Hong Kong, CHN.

We report an unusual case of metastatic papillary thyroid carcinoma presenting with progressive neck pain in a 58-year-old female with known bilateral thyroid nodules. Despite initial benign ultrasonographic findings and trials of conservative therapy for over 2 months, the patient's anterior neck pain and unremitting symptoms prompted concern regarding an underlying orthopedic condition. She sought chiropractic consultation, and MRI revealed pathologic vertebral fractures. Read More

View Article and Full-Text PDF

Predictive factors for nodal recurrence in differentiated thyroid cancers.

Cancer Treat Res Commun 2023 16;36:100728. Epub 2023 Jun 16.

Department of Biostatistics, Regional Cancer Centre, Thiruvananthapuram, India.

Introduction: Differentiated thyroid carcinoma usually has a good prognosis. Primary treatment is surgery, followed by radioactive iodine ablation based on risk stratification. The incidence of local and distant recurrence is 30%. Read More

View Article and Full-Text PDF
September 2023

Integrated metabolic and genetic analysis reveals distinct features of human differentiated thyroid cancer.

Clin Transl Med 2023 Jun;13(6):e1298

Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.

Background: Differentiated thyroid cancer (DTC) affects thousands of lives worldwide each year. Typically, DTC is a treatable disease with a good prognosis. Yet, some patients are subjected to partial or total thyroidectomy and radioiodine therapy to prevent local disease recurrence and metastasis. Read More

View Article and Full-Text PDF

Early Post-operative Stimulated Serum Thyroglobulin: Role in Preventing Unnecessary Radioactive Iodine Treatment in Low to Intermediate Risk Papillary Thyroid Cancer.

Am Surg 2023 Jun 13:31348231157816. Epub 2023 Jun 13.

Department of Endocrinology and Medicine, Koç University, Istanbul, Turkey.

Aim: The aims of the study are to evaluate the predictive value of early post-operative stimulated thyroglobulin (sTg) analysis on the recurrence risk, and to define a cut-off value that is related to recurrence risk in low to intermediate risk papillary thyroid cancer (PTC).

Methods: This retrospective cohort study included individuals who were diagnosed with PTC aged 18 years or older and had been operated by experienced surgeons of a tertiary university hospital between the years 2011 and 2021. The American Thyroid Association thyroid cancer guidelines version 2015 was used as the risk stratification system. Read More

View Article and Full-Text PDF

Clinical characteristics of primary parathyroid adenoma and its relationship with coexisting papillary thyroid carcinoma: a clinical retrospective study.

Gland Surg 2023 May 11;12(5):577-585. Epub 2023 Apr 11.

Department of Thyroid and Breast Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Background: Parathyroid adenoma (PA) is a common but relatively poorly understood endocrine tumor. A significant number of PA patients also have papillary thyroid carcinoma (PTC). The clinicopathological characteristics of PA and its relationship with PTC need further study. Read More

View Article and Full-Text PDF

Distant Metastasis as the First Presentation of Thyroid Carcinoma.

Indian J Otolaryngol Head Neck Surg 2023 Jun 8;75(2):1020-1023. Epub 2022 Dec 8.

Tehran, Iran Emergency Medicine, Sina Hospital, Tehran University of Medical Sciences.

Introduction: Thyroid carcinoma is the most common endocrine cancer which may manifest with unusual presentations. We addressed distant metastases as the first presentations of thyroid carcinoma in several patients, though previously considered to occur rarely.

Methods: In this case series, 10 patients are introduced with signs and symptoms of distant metastasis. Read More

View Article and Full-Text PDF

Identification of key immune genes related to lymphatic metastasis of papillary thyroid cancer via bioinformatics analysis and experimental validation.

Front Oncol 2023 18;13:1181325. Epub 2023 May 18.

Department of General Surgery, Baoding First Central Hospital, Baoding, Hebei, China.

Objective: The current research aimed to development and validation in signature immune genes for lymphatic metastasis in papillary thyroid cancer (PTC).

Method: Weighted correlation network analysis (WGCNA) was performed to identify genes closely correlated with lymphatic metastasis in PTC from TCGA database. Information on immune-related genes (IRGs) was obtained from the ImmPort database. Read More

View Article and Full-Text PDF

Factors Affecting Ablation Success After I-131 Radioactive Iodine Therapy in Low and Intermediate Risk Papillary Thyroid Cancer.

Horm Metab Res 2023 Jun 2. Epub 2023 Jun 2.

Endocrinology, Recep Tayyip Erdoğan University, Rize, Turkey.

The study was to evaluate the effect of radioactive iodine (RAI) treatment application time and clinical, histopathological factors on ablation success in patients with operated papillary thyroid cancer (PTC) in low and intermediate-risk. One hundred sixty-one patients with PTC in the low and intermediate-risk were evaluated. Most patients (89. Read More

View Article and Full-Text PDF

Predictive value of systemic inflammatory markers for recurrence of papillary thyroid cancer.

J Surg Oncol 2023 Oct 27;128(5):743-748. Epub 2023 May 27.

Department of General Surgery, Lianyungang Oriental Hospital, Lianyungang, Jiangsu, China.

Background: Papillary thyroid cancer (PTC) is the most common type of differentiated thyroid cancer. Early identification of patients at higher risk of recurrence may allow to improve relevant follow-up strategies and plan tailored treatment. Inflammation play an important role in the prognosis of cancer. Read More

View Article and Full-Text PDF
October 2023

Fibronectin Contributes to a BRAF Inhibitor-driven Invasive Phenotype in Thyroid Cancer through EGR1, Which Can Be Blocked by Inhibition of ERK1/2.

Mol Cancer Res 2023 Sep;21(9):867-880

Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado.

Unlabelled: Mutations in BRAF are common in advanced papillary and anaplastic thyroid cancer (PTC and ATC). However, patients with BRAF-mutant PTC currently lack therapies targeting this pathway. Despite the approved combination of BRAF and MEK1/2 inhibition for patients with BRAF-mutant ATC, these patients often progress. Read More

View Article and Full-Text PDF
September 2023